Owen Mumford

Activities: Manufacturing Drug Delivery

Trending Articles

  1. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  2. Manufacturing Chemist Stand Side with Piramal Pharma Solutions We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  3. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  4. One in four European pharma companies at risk of regulatory breaches according to NSF research The independent survey exposed significant gaps in quality systems, supply chain oversight and data integration, just as EU GMP regulations continue to tighten
  5. IWK introduces machine to produce 100% cardboard blister packaging CABLIblue 870 features innovative “card-to-card” technology for recyclable, fiber-based blisters

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Drug Delivery

Owen Mumford launches EcoSafe safety syringe platform

Medical device expert Owen Mumford has extended its 1 mL safety syringe platform by adding a companion reusable autoinjector.
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Autoinjector platforms: optimising device selection and unlocking manufacturing efficiency for injectable pipelines

Owing to ageing populations, the increased prevalence of chronic disease and additional pressure on global healthcare systems, among other factors, the market for drug delivery devices for self-administration (autoinjectors) is growing
Drug Delivery

Nipro and Owen Mumford partner to distribute drug delivery device, UniSafe

The medical device is a patient-centric method for the delivery of injectable medicines, and is designed to enhance compliance
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Creating a framework to measure the impact of drug delivery devices

Alex Fong, Insights and Sustainability Lead at Owen Mumford, discusses the company’s lifecycle assessment (LCA) journey
Manufacturing

Owen Mumford’s near-term and net-zero targets approved by the SBTi

The company's long and short-term initiatives include the reduction of scope 1, 2 and 3 emissions by 42% by 2030, as well as reaching net-zero in greenhouse gas emissions
Drug Delivery

Expanding capacity through collaboration

Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems, Stevanato Group, talk to Dr Kevin Robinson about their new partnership
Manufacturing

Owen Mumford refurbishment project completed by Efaflex

An Efaflex case study
Subscribe now